With virus cases rising and the holidays nigh, three expert from University of Michigan Health give their top 12 tips for avoiding or reducing the impact of COVID-19, flu, RSV, pneumonia and whooping cough in adults and kids.
The new study is among the first to quantify unmet demand for the vaccine — people who would be willing to be vaccinated if they had access.
Not for public release
This news release is embargoed until 11-Dec-2023 5:00 PM EST
Released to reporters: 5-Dec-2023 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 11-Dec-2023 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
According to new predictions by La Jolla Institute for Immunology (LJI) researchers, if the new SARS-CoV-2 Pirola variant wants to evade T cells, it isn't doing a very good job.
Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body. They have identified the sequence within the mRNA that causes this to occur and found a way to prevent ‘off-target’ immune responses to enable the safer design of future mRNA therapeutics.
With the holiday season underway, and families and friends gathering to celebrate, a leading Cedars-Sinai Guerin Children’s pediatrician has one word of advice for parents: Vaccinate.
Darcy Dunn-Lawless, a doctoral student at the University of Oxford, is investigating the potential of a painless, needle-free vaccine delivery by ultrasound. The method uses cavitation, which is the formation and popping of bubbles in response to a sound wave. Though initial in vivo tests reported 700 times fewer vaccine molecules were delivered by the cavitation approach compared to conventional injection, the cavitation approach produced a higher immune response. The researchers theorize this could be due to the immune-rich skin the ultrasonic delivery targets. The result is a more efficient vaccine that could help reduce costs and increase efficacy.
In a paper published in The Journal of Infectious Diseases, Daniel Hoft, M.D., Ph.D., director of the Saint Louis University Center for Vaccine Development, and colleagues report a promising new approach to speed vaccine testing for TB.
Press conferences for Acoustics 2023 Sydney will be held virtually at 8:00 a.m. AEDT, Dec. 6 and Dec. 7. Topics will focus on a wide range of newsworthy sessions from the upcoming meeting, which runs Dec. 4-8 in Sydney, Australia.
During the first two years of the pandemic, a COVID-19 infection during pregnancy increased the risk of preterm birth and NICU hospitalizations.
Not for public release
This news release is embargoed until 27-Nov-2023 5:00 PM EST
Released to reporters: 20-Nov-2023 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 27-Nov-2023 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Clarivate calls these scientists "pioneers," noting that ranking on the Highly Cited Researchers list is a sign that a scientist has published significant findings and influenced their field of study.
Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19.
An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.
Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, according to a new national survey by The Ohio State University Wexner Medical Center.